HeyJaredBarbara Zenz
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
Aging With HIV: Is Care Keeping Up With Changing Needs? (opens the original)
Read excerpt
Highly effective antiretroviral combination therapy (ART) has transformed HIV infection from a condition associated with a substantially shortened life expectancy into a manageable chronic disease. Simultaneously, the demographics of HIV infections have changed. Fewer individuals are acquiring HIV as awareness has increased, and effective prevention with HIV preexposure prophylaxis has become available. Meanwhile, individuals with HIV receiving ART are living to older ages despite age-related an
COVID, 6 Years on: The Pandemicâs Long Clinical Shadow (opens the original)
Read excerpt
The COVID pandemic was officially declared over more than 3 years ago. Today, 6 years after the identification of SARS-CoV-2 — the virus that brought much of the world to a near standstill — fear of infection seems to have all but disappeared. Although various aspects of the pandemic continue to be debated, COVID has largely faded from public consciousness as a potentially severe illness. On the one hand, this is because nearly all subvariants currently circulating are descendants of the compara
Eradication of Measles and Polio: Why Has Progress Stalled? (opens the original)
Read excerpt
Routine childhood and adolescent vaccinations, as outlined in national immunization schedules, have significantly reduced the burden of many dangerous infectious diseases over the past few decades. Some have become so rare that even physicians rarely encounter them in daily practice, whereas others that still cause preventable deaths — particularly among children and adolescents — should no longer exist. These diseases meet the criteria for potential eradication: Transmission occurs exclusively
Can CRISPR Make CAR T Safer and More Scalable? (opens the original)
Read excerpt
The introduction of chimeric antigen receptor (CAR) T-cell therapies marked a major advance in treating B-cell lymphomas and leukemias. Almost 10 years have passed since the first CAR T-cell therapy was approved, during which time this novel form of therapy has been further developed. Several preparations are now available, each individually manufactured for a specific patient. For production, the patient’s own T cells are isolated, genetically modified, and reinfused to exert their efficacy wit
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.